Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ResearchAndMarkets.com's offering.
The sector report provides comprehensive information about the Transdermal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The report provides detailed coverage of the transdermal drug delivery systems currently under development, offering insights into the evolving landscape of this drug delivery method. It includes comprehensive information on major pipeline products, complete with descriptions, licensing, collaborations, and other developmental activities crucial to understanding the market's dynamics.
In addition to product specifics, the report reviews the major players in the transdermal drug delivery sector, listing all their ongoing projects and showcasing the competitive environment. It categorizes the coverage of pipeline products according to their development stages, ranging from early development to products that have been approved or issued, giving a clear view of the market's maturity and the progress of various initiatives.
Crucially, the report incorporates key clinical trial data relevant to ongoing trials specific to pipeline products, providing a critical resource for stakeholders interested in the latest research and development efforts. It also addresses recent developments within the transdermal drug delivery segment, capturing the latest advancements, regulatory updates, and industry trends that are shaping the future of non-invasive drug delivery technologies. This comprehensive approach ensures that readers are well-informed of the current state and potential future trajectories in transdermal drug delivery.
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Transdermal Drug Delivery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Transdermal Drug Delivery Overview
3 Products under Development
3.1 Transdermal Drug Delivery - Pipeline Products by Stage of Development
3.2 Transdermal Drug Delivery - Pipeline Products by Segment
3.3 Transdermal Drug Delivery - Pipeline Products by Territory
3.4 Transdermal Drug Delivery - Pipeline Products by Regulatory Path
3.5 Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
3.6 Transdermal Drug Delivery - Ongoing Clinical Trials
4 Transdermal Drug Delivery - Pipeline Products under Development by Companies
4.1 Transdermal Drug Delivery Companies - Pipeline Products by Stage of Development
4.2 Transdermal Drug Delivery - Pipeline Products by Stage of Development
5 Transdermal Drug Delivery Companies and Product Overview
6 Transdermal Drug Delivery- Recent Developments
7 Appendix
A selection of companies mentioned in this report includes, but is not limited to:
- 3P Biotechnologies Inc
- AbbVie Inc
- Abionic SA
- Actuated Medical Inc
- AcusMu Medtech Co Ltd
- Adynxx Inc
- Aequus Pharmaceuticals Inc
- AerMedX Ltd
- Agile Therapeutics Inc
- American Chemical Society
- AMW GmbH
- Amzell BV
- Anodyne Nanotech Inc
- Apogee Technology Inc
- Asahi Kasei Pharma Corp
- ASCIL Biopharm
- Avecho Biotechnology Ltd
- Avro Life Sciences
- Better Life Pharmaceuticals Inc
- BioNxt Solutions Inc
- Boryung Pharmaceutical Co Ltd
- Burke Pharmaceuticals LLC
- Candesant Biomedical Inc
- Carnegie Mellon University
- Cassava Sciences Inc
- CB Scientific Inc
- Celltrion Inc
- Cerimon Pharmaceuticals, Inc. (Inactive)
- Changchun University of Chinese Medicine
- Chrono Therapeutics Inc
- Cipla Ltd
- Clexio Biosciences Ltd
- Corium LLC
- CS Medica A/S
- Daewon Pharmaceutical Co Ltd
- Daewoong Pharmaceutical Co Ltd
- DBV Technologies SA
- DD Therapeutics LLC (Inactive)
- Delpor Inc
- Dermisonics Inc
- Dharma Therapeutics, Inc. (Inactive)
- Dong-A ST Co Ltd
- Drexel University
- DURECT Corp
- Echo Therapeutics Inc (Inactive)
- Emplicure AB
- Endo International Plc
- Endomimetics LLC
- Extend Biosciences Inc
- Fe3 Medical Inc
- Feplen Health Research Pvt Ltd
- Futura Medical Plc
- Georgetown University
- Georgia Institute of Technology
- Georgia State University
- Gerresheimer AG
- GlobeStar Therapeutics Corp
- Gylden Pharma Limited
- Henley Ion LLC
- Hera Health Solutions
- Hisamitsu Pharmaceutical Co Inc
- I.M. Sechenov First Moscow State Medical University
- Icure Pharmaceutical Inc
- ImmunoMatrix LLC
- ImmuPatch
- Indian Institute of Science
- Indian Institute of Technology Bombay
- Indian Institute of Technology Hyderabad
- Indian Institute of Technology, Kanpur
- InMed Pharmaceuticals Inc
- Institute of Materials Research & Engineering
- InteguRx Therapeutics LLC
- Intercell AG (Inactive)
- Interstitial NS
- Isis Biopolymer Inc (Inactive)
- James J. Peters VA Medical Center
- Janisys
- Jiaxing Xinwen Biotechnology Co Ltd
- Karolinska Institute
- Kindeva Drug Delivery LP
- KTH Royal Institute of Technology
- Leo Pharma AS
- Libero Pharma Ltd
- Livzon Pharmaceutical Group Inc
- LTS Lohmann Therapie-Systeme AG
- Luye Pharma Group Ltd
- Massachusetts Institute of Technology
- Mayne Pharma Group Ltd
- Medherant Ltd
- MEDRx Co Ltd
- Microdermics Inc
- Micron Biomedical Inc
- Micropoint Technologies Pte Ltd
- Mineed Technology Co Ltd
- Mycrodose Therapeutics Inc
- MyLife Technologies
- Nanyang Technological University
- National Dental Centre Singapore
- National University of Singapore
- nCap Medical LLC
- Nemaura Pharma Ltd
- NeuroDerm Ltd
- Nexgel Inc
- Nitto Denko Corp
- North Carolina State University
- Nova Graphene Ballistics Inc
- Noven Pharmaceuticals Inc
- NutriBand Inc
- Nuvo Pharmaceuticals Inc (Inactive)
- Ohio State University
- Old Dominion University
- Osprey Medical Inc
- Pantec Biosolutions AG
- PassPort Technologies Inc
- PATH
- Pebble Inc
- PharmaTher Holdings Ltd
- Privo Technologies Inc
- Prometheon Pharma LLC
- Purdue University
- Quadmedicine
- Quoin Pharmaceuticals Inc
- Radius Health Inc
- Raphas Co Ltd
- Rescue Biomedical LLC
- Resilient Lifescience Inc
- Ryah Medtech Inc
- Sanofi
- Satio Inc
- Seelos Therapeutics, Inc.
- Serina Therapeutics Inc
- Shenox Pharmaceuticals LLC
- Sichuan Kelun Pharmaceutical Co Ltd
- Sinsin Pharmaceutical Co Ltd
- Skinject Inc
- Sorrento Therapeutics Inc (Inactive)
- Sparsha Pharma International Pvt Ltd
- Sree Chitra Tirunal Institute for Medical Sciences & Technology
- Stanford University
- Starton Therapeutics Inc
- Suzhou Reveda Medical Co Ltd
- Swansea University
- Syntropharma Ltd (Inactive)
- Taho Pharmaceuticals Ltd
- Teikoku Pharma USA Inc
- tesa Labtec GmbH
- Tetra Pharm Technologies ApS
- Teva Pharmaceutical Industries Ltd
- Texas Tech University
- The Sheikh Zayed Institute for Pediatric Surgical Innovation
- TheraJect Inc
- Therapeutic Systems Research Laboratories Inc
- TheraSolve NV (Inactive)
- Theratech, Inc.
- Theris Medical Inc
- Titan Pharmaceuticals Inc
- Transcu Group Limited (Inactive)
- Transdermal Delivery Solutions Corp
- Transdermal Specialties Inc
- Transform SciTech Pvt Ltd
- TransPharma Medical Ltd (Inactive)
- Transport Pharmaceuticals Inc
- University of Connecticut Health Center
- University of Helsinki
- University of Hong Kong
- University of Illinois at Chicago
- University of Iowa
- University of Kentucky
- University of North Carolina
- University of Pittsburgh
- University of South Florida
- University of the Philippines Manila
- University of the Witwatersrand
- University of Tokyo
- University of Toronto
- University of Washington
- Vaxess Technologies Inc
- Vaxxas Pty Ltd
- Veradermics Inc
- Viatris Inc
- ViiV Healthcare UK Ltd
- Virpax Pharmaceuticals Inc
- Vyteris, Inc. (Inactive)
- Wellfully Ltd
- Xel Pharmaceuticals Inc (Inactive)
- Zambon Italia Srl
- Z-Cube Srl
- Zosano Pharma Corp
- Zylo Therapeutics LLC
- Zynerba Pharmaceuticals Inc
For more information about this report visit https://www.researchandmarkets.com/r/u271ic
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
